Cellular Dynamics International Inc., a firm founded by stem cell pioneer James Thomson of the University of Wisconsin-Madison, said Wednesday that its researchers have generated pluripotent stem cells from small volumes of human blood samples.
The stem cells, which have the ability to generate all tissue types in the body, pose the potential of establishing new cellular therapies for disease. Generating pluripotent stem cells from human blood samples, either freshly collected or stored in repositories, provides a convenient source of patient-specific stem cells that can be used for personalized treatments.
"The ability to use common tissue repositories to create iPS (induced pluripotent stem) cells from donors with known medical history enables us to provide the pharmaceutical industry with a cell portfolio representing individual biology, disease models, retrospective analysis and ethnic diversity," Emile Nuwaysir, chief operations officer of CDI. "This is the first step in paving the way for large-scale processing and industrialization of iPS cells."
The findings will be presented during a poster session beginning July 10 at the International Society for Stem Cell Research annual meeting in Barcelona, Spain.
Cellular Dynamics International in Madison is a developer of next-generation stem cell technologies for drug development and personalized medicine applications.
No comments:
Post a Comment